Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Review
Drugs
2025
Famitinib: First Approval.
Susan J Keam
PubMed ↗
Publisher ↗
No numbers read from the abstract.
1 paper cites it
2025
2026
this paper
trial
cites it
Famitinib: First Approval. | OpenQuestion